Bright Minds Biosciences, Inc. (DRUG)
50.75
-1.25
(-2.40%)
USD |
NASDAQ |
Oct 08, 12:31
Bright Minds Biosciences Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Amgen, Inc. | 24.86% |
| Lineage Cell Therapeutics, Inc. | 87.55% |
| Recursion Pharmaceuticals, Inc. | 93.13% |
| Agenus, Inc. | 98.84% |
| BioCryst Pharmaceuticals, Inc. | 79.10% |